Navigation Links
FreshFx Recognized for use in the Scalder as a Solution to the 'Yield/Pathogen Reduction Dilemma'
Date:11/6/2007

Article in Watt Poultry USA states that acidic treatments benefit poultry

processing plants.

SHREVEPORT, La., Nov. 6 /PRNewswire/ -- FreshFx Antimicrobial Solution, which is used to reduce pathogens during poultry processing, was identified in an October 2007 Watt Poultry USA article as helping to solve the "yield/pathogen reduction dilemma."

Citing recent studies in large-scale processing plants, University of Georgia Associate Professor of Poultry Science Scott Russell, Ph.D., stated that adding an acidic disinfectant chemical (such as FreshFx) during scalding "benefits the system, allowing scalder temperatures to be lowered without the concern that Salmonella will begin to grow. And, acids greatly improve picking."

FreshFx is USDA-approved for use anywhere along the processing line: pre-evisceration in the scalder, over picking rails and in the New York rinse; throughout evisceration and for on-line reprocessing (OLR) as rinses or dips; and for pH control in the chillers, as well as post-chill. Since its approval as a processing aid in January 2003, FreshFx has been used to disinfect nearly 2 billion birds.

"FreshFx can maintain antimicrobial activity even in the presence of the accumulated organic load found in scalder water and other immersion systems," said John Dankert, Ph.D., CEO of SteriFx Inc., which manufactures FreshFx. "This contrasts sharply with alternatives that would 'gas-off' at high temperatures or be inhibited by the organic load, reducing effectiveness."

The ability to use lower temperatures for scalding reduces energy costs and decreases the amount of fats and oils that are released, which enhances antimicrobial effectiveness. Also, when less fats and oils are released, an increase in yield not related to moisture might be obtained.

Of course, lower temperatures can also create an environment where Salmonella and other pathogens can thrive, and also lead to less efficient p
'/>"/>

SOURCE SteriFx Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
2. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
3. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
4. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
5. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
6. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
7. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
8. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
11. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... ARBOR, Mich. , Sept. 18, 2014  A ... Research will allow the University of Michigan to establish ... The Glenn Center for Aging Research at ... evidence that drugs can slow the effects of aging ... unlock mechanisms of aging that can help develop medications ...
(Date:9/18/2014)... SAN DIEGO , Sept. 18, 2014 /PRNewswire/ ... today announced that the U.S. Food and Drug ... patient enrollment and dosing of PEGPH20 in SWOG,s ... is designed to evaluate Halozyme,s investigational drug PEGPH20 ... FOLFIRINOX chemotherapy (mFOLFIRINOX) in patients with metastatic pancreatic ...
(Date:9/18/2014)... -- Australian biomarker discovery company Minomic International Ltd will ... prostate cancer screening test, planning to achieve US Food ... Minomic,s proprietary MiStat™ technology is a screening assay ... known as the MIL-38 antigen. This biomarker is present ... Researchers at 11 leading urology centres in ...
Breaking Medicine Technology:$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2
... , ALLEGAN, Mich. , Jan. 19 ... release financial results for its second quarter fiscal 2010 on Tuesday, ... Company will conduct a conference call at 10:00 a.m. (ET) ... Officer. , The conference call will be available live via webcast to ...
... LAKE CITY , Jan. 19 World Heart ... circulatory systems, announced today that the first U.S. implant of ... INTEGRIS Baptist Medical Center ("INTEGRIS") in Oklahoma City ... the first implant in the Levacor VAD bridge-to-transplant ("BTT") study, ...
Cached Medicine Technology:Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010 2WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City 2WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City 3
(Date:9/18/2014)... Throughout their lives, sisters support each other. ... their achievements and accomplishments together, and lend helping hands. ... Joanie’s Sisters in Support, a support sorority, does all ... their battles against breast and ovarian cancers – a ... in June, meets once a month at the Joanie ...
(Date:9/18/2014)... professor Robert Campbell (Ophthalmology) has revealed using anti-inflammatory medications ... Glaucoma is the most common cause of irreversible blindness ... with the disease, which is mainly caused by pressure ... optic nerve. The optic nerve is responsible for sending ... a vital part of vision., "The use of strong ...
(Date:9/18/2014)... Massachusetts, U.S.A., September 18, 2014 -- BGI Tech ... service to Denmark-based DLF-Trifolium and the Department of ... in an effort to develop a series of ... selection (GS) methods. , GS is a new ... to the traditional QTL-based selection, uses information equally ...
(Date:9/18/2014)... 18, 2014 Good Neighbor Pharmacy, ... of Good Neighbor Pharmacy University, an online central ... will educate and empower pharmacy owners and their ... industry continues to evolve, Good Neighbor Pharmacy is ... resources and tools to help their businesses thrive,” ...
(Date:9/18/2014)... new expert panel report, Improving Medicines for Children ... Canadian Academies, addresses the importance of developing safe ... half of Canada,s seven million children use at ... is done off-label (i.e. the prescription differs from ... have historically been excluded in drug research and ...
Breaking Medicine News(10 mins):Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 2Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 3Health News:BGI Tech, DLF-Trifolium A/S, and Aarhus University applying genomic selection methods 2Health News:Good Neighbor Pharmacy University Keeps Pharmacists Ahead of the Curve 2Health News:Improving medicines for children in Canada 2
... ... the opening keynote address to more than 8,000 professionals from the biopharmaceutical and related sectors ... ... Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA), will deliver the opening ...
... 4 Sixty-one-year old Joanne Bogan is being treated for two ... living with multiple sclerosis. Both are healthier today thanks to ... its innovative model of care. The ground-breaking story of Eleventh ... today by the Center to Champion Nursing in America ...
... NEW YORK, Nov. 4 Today, St. Jude Children,s Research ... campaign, an unprecedented union of celebrities, media, retail and corporate ... kids in your life, and give to those who are ... , national outreach director for St. Jude. , For ...
... Celsius Holdings, Inc. (OTC Bulletin Board:CSUH.OB), maker of Celsius®, ... host a conference call on Tuesday, November 10, 2009, beginning ... quarter 2009 financial results. The call will be open to ... will provide opportunity for real time questions and answers. , ...
... family size increases, study finds, , WEDNESDAY, Nov. 4 (HealthDay ... having kids. , A new study found that having children ... But unmarried couples shouldn,t expect to find greater happiness through ... of the Journal of Happiness Studies , suggests that ...
... DIEGO, Nov. 4 NovaRx Corporation announced today that ... for a Special Protocol Assessment (SPA) Protocol Amendment to ... with Non-Small Cell Lung Cancer (NSCLC). The amendment will ... patients with stable brain metastases. As many as one ...
Cached Medicine News:Health News:FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DC , 2Health News:FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DC , 3Health News:Drexel University's Eleventh Street Health Services Recognized as National Model of Innovative Health Care 2Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 2Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 3Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 4Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 5Health News:Celsius Holdings, Inc. Invites You to Join its Third Quarter 2009 Financial Results Conference Call on Tuesday, November 10, 2009, at 4:30 p.m. Eastern 2Health News:Married With Children Paves Way to Happiness 2Health News:NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer (NSCLC) 2Health News:NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer (NSCLC) 3
Straight shafts with 0.5 mm teeth and 6 mm tying platform. Wide serrated handle with thumb catch lock and polished finish....
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Straight shafts with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in the closed position. Polished finish. Tips: 0.12 mm teeth....
Medicine Products: